Search research articles
Contact Us
Filters
Showing results (41-50 of 485) with videos related to
Page
of 49
Sort By:
Advances in Therapy
|
December 30, 2020
Recombinant FVIIIFc Versus BAY 94-9027 for Treatment of Patients with Haemophilia A: Comparative Efficacy Using a Matching Adjusted Indirect Comparison
Zalmai Hakimi, Elena Santagostino, Maarten J Postma, et al.
Journal of Medical Economics
|
March 16, 2026
Cost per event avoided: adopt or avoid?
P Petrou, Olga Pitsillidou, Constantinos Petrou, et al.
Frontiers in Medical Technology
|
January 20, 2022
Efficacy, Safety, and Economics of Innovative Medicines: The Role of Multi-Criteria Decision Analysis and Managed Entry Agreements in Practice and Policy
Tanja Fens, Eugène P van Puijenbroek, Maarten J Postma
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 25, 2022
Differences in Evidentiary Requirements Between European Medicines Agency and European Health Technology Assessment of Oncology Drugs-Can Alignment Be Enhanced?
Sharon Wolters, Frank G A Jansman, Maarten J Postma
Expert Review of Pharmacoeconomics & Outcomes Research
|
February 23, 2018
Access to anti-cancer drugs in India: is there a need to revise reimbursement policies?
Gertruud Haitsma, Himanshu Patel, Parthasarathi Gurumurthy, et al.
Vaccine
|
July 4, 2012
Cost-effectiveness of pertussis booster vaccination in the Netherlands
Mark H Rozenbaum, Elisabetta De Cao, Maarten J Postma
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
March 14, 2024
Antivirals to prepare for surges in influenza cases: an economic evaluation of baloxavir marboxil for the Netherlands
Simon van der Pol, Maarten J Postma, Cornelis Boersma
Expert Review of Vaccines
|
January 10, 2025
Controlling the COVID-19 pandemic through vaccination: a perspective from Indonesia
Rano K Sinuraya, Auliya A Suwantika, Maarten J Postma
Pharmaceutical Statistics
|
May 12, 2015
An alternative parameterization of Bayesian logistic hierarchical models for mixed treatment comparisons
Petros Pechlivanoglou, Fentaw Abegaz, Maarten J Postma, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
October 8, 2009
The use of modeling in the economic evaluation of vaccines
Jasper M Bos, Loek van Alphen, Maarten J Postma
Page
of 49
Search research articles
Search
Showing results (41-50 of 485) with videos related to
Sort By:
Page
of 49
Advances in Therapy
|
December 30, 2020
Recombinant FVIIIFc Versus BAY 94-9027 for Treatment of Patients with Haemophilia A: Comparative Efficacy Using a Matching Adjusted Indirect Comparison
Zalmai Hakimi, Elena Santagostino, Maarten J Postma, et al.
Journal of Medical Economics
|
March 16, 2026
Cost per event avoided: adopt or avoid?
P Petrou, Olga Pitsillidou, Constantinos Petrou, et al.
Frontiers in Medical Technology
|
January 20, 2022
Efficacy, Safety, and Economics of Innovative Medicines: The Role of Multi-Criteria Decision Analysis and Managed Entry Agreements in Practice and Policy
Tanja Fens, Eugène P van Puijenbroek, Maarten J Postma
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 25, 2022
Differences in Evidentiary Requirements Between European Medicines Agency and European Health Technology Assessment of Oncology Drugs-Can Alignment Be Enhanced?
Sharon Wolters, Frank G A Jansman, Maarten J Postma
Expert Review of Pharmacoeconomics & Outcomes Research
|
February 23, 2018
Access to anti-cancer drugs in India: is there a need to revise reimbursement policies?
Gertruud Haitsma, Himanshu Patel, Parthasarathi Gurumurthy, et al.
Vaccine
|
July 4, 2012
Cost-effectiveness of pertussis booster vaccination in the Netherlands
Mark H Rozenbaum, Elisabetta De Cao, Maarten J Postma
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
March 14, 2024
Antivirals to prepare for surges in influenza cases: an economic evaluation of baloxavir marboxil for the Netherlands
Simon van der Pol, Maarten J Postma, Cornelis Boersma
Expert Review of Vaccines
|
January 10, 2025
Controlling the COVID-19 pandemic through vaccination: a perspective from Indonesia
Rano K Sinuraya, Auliya A Suwantika, Maarten J Postma
Pharmaceutical Statistics
|
May 12, 2015
An alternative parameterization of Bayesian logistic hierarchical models for mixed treatment comparisons
Petros Pechlivanoglou, Fentaw Abegaz, Maarten J Postma, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
October 8, 2009
The use of modeling in the economic evaluation of vaccines
Jasper M Bos, Loek van Alphen, Maarten J Postma
Page
of 49